This database includes peer-reviewed publications authored or funded by TB Alliance. Use the tags on the right to filter by subject, or search for a particular author or term using the search bar.
Displaying 158 papers
An Assessment of Global Chemistry, Manufacturing and Controls (CMC) Regulatory Requirements in Low and Middle Income Countries
11/2018 - WHO Drugs Journal
10/2018 - BMC Medicine (2018) 16:189
7/2018 - BMC Infectious Diseases
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.
5/2018 - BMC Medicine
3/2018 - BMC Medicine
Antitubercular nitroimidazoles revisited: synthesis and activity of the authentic 3-nitro isomer of pretomanid
12/2017 - ACS Medicinal Chemistry Letters
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis
12/2017 - BMC Medicine 2017 15:207
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
12/2017 - BMC Medicine 2017 15:207
Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units
10/2017 - Bioorganic & Medicinal Chemistry Letters
5/2017 - Bulletin of the World Health Organization
The impact of HIV and antiretroviral therapy on TB risk in children: A systematic review and meta-analysis
1/2017 - Thorax Online, 23 Jan. 2017. Web. 31 Jan. 2017.
12/2016 - The International Journal of Tuberculosis and Lung Disease
10/2016 - Tuberculosis.Nature Reviews Disease Primers. 2016/10/27/online. 16076. Macmillan Publishers Limited. http://dx.doi.org/10.1038/nrdp.2016.76
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and ﬂ uoroquinolones: results from a multicountry surveillance project
7/2016 - Zignol, Matteo, Anna Dean, and Natavan Alikhanova. "Population-based Resistance of Mycobacterium Tuberculosis." The Lancet (Published Online July 7, 2016 Http://dx.doi.org/10.1016/S1473-3099(16)30190-6):
Developing a Framework for Evaluating Ethical Outcomes of Good Participatory Practices in TB Clinical Drug Trials
6/2016 - Journal of Empirical Research on Human Research Ethics 1556264616657452, first published on June 30, 2016 doi:10.1177/1556264616657452
6/2016 - Peter J Dodd, Charalambos Sismanidis, James A Seddon. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. The Lancet Infectious Diseases , Volume 0 , Issue 0
3/2016 - Yamey G, Morel C. Investing in Health Innovation: A Cornerstone to Achieving Global Health Convergence. PLOS Biology. 2016 Mar 1;14(3). doi: 10.1371/journal.pbio.1002389.
The Zika Loopholes: The FDA has a smart-sounding program to drive research for neglected diseases—with two big flaws
3/2016 - Brock WR, Cohen R, Cone J, McKenna L. The Zika Loopholes: The FDA.... March 25, 2016. http://www.politico.com/agenda/story/2016/03/the-right-way-to-encourage-companies-to-develop-a-treatment-for-zika-000079. Accessed March 25, 2016.
"Understanding and addressing the tuberculosis case detection gap national inventory studies to improve estimates of incidence and strengthen surveillance" with comments
3/2016 - Sismanidis C, Glaziou P, Bloss E, et. al. "Understanding and addressing the tuberculosis case detection gap national inventory studies to improve estimates of incidence and strengthen surveillance" with comments. 2016 Mar
Understanding and addressing the tuberculosis case detection gap national inventory studies to improve estimates of incidence and strengthen surveillance
3/2016 - Sismanidis C, Glaziou P, Bloss E, et. al. Understanding and addressing the tuberculosis case detection gap national inventory studies to improve estimates of incidence and strengthen surveillance. 2016 Mar.